Ketogenic diet does not promote triple-negative and luminal mammary tumor growth and metastasis in experimental mice
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Ketogenic diet does not promote triple-negative and luminal mammary tumor growth and metastasis in experimental mice ; day:9 ; month:12 ; year:2023 ; pages:1-16
Clinical & experimental metastasis ; (9.12.2023), 1-16
- Classification
-
Medizin, Gesundheit
- Creator
-
Grube, Meret
Dimmler, Arno
Schmaus, Anja
Saup, Rafael
Wagner, Tabea
Garvalov, Boyan K.
Sleeman, Jonathan P.
Thiele, Wilko
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s10585-023-10249-z
- URN
-
urn:nbn:de:101:1-2024022611133377889962
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 11:00 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Grube, Meret
- Dimmler, Arno
- Schmaus, Anja
- Saup, Rafael
- Wagner, Tabea
- Garvalov, Boyan K.
- Sleeman, Jonathan P.
- Thiele, Wilko
- SpringerLink (Online service)
Other Objects (12)
Mammary adipocytes protect triple-negative breast cancer cells from ferroptosis
Mouse mammary stem cells express prognostic markers for triple-negative breast cancer
Luminal androgen receptor subtype and tumor-infiltrating lymphocytes groups based on triple-negative breast cancer molecular subclassification
Multipotent luminal mammary cancer stem cells model tumor heterogeneity
Metastatic Triple-Negative Breast Cancer
Prognostic value of proliferation assay in the luminal, HER2-positive, and triple-negative biologic classes of breast cancer
Desmoglein 2 and desmocollin 2 depletions promote malignancy through distinct mechanisms in triple-negative and luminal breast cancer
Triple-negative vimentin-positive heterogeneous feline mammary carcinomas as a potential comparative model for breast cancer
A novel approach to triple-negative breast cancer molecular classification reveals a luminal immune-positive subgroup with good prognoses
BRCAness digitalMLPA profiling predicts benefit of intensified platinum-based chemotherapy in triple-negative and luminal-type breast cancer
Characterizing triple-negative breast cancer tumors
Triple-Negative Breast Cancer: Multimodality Appearance
Mammary adipocytes protect triple-negative breast cancer cells from ferroptosis
Mouse mammary stem cells express prognostic markers for triple-negative breast cancer
Luminal androgen receptor subtype and tumor-infiltrating lymphocytes groups based on triple-negative breast cancer molecular subclassification
Multipotent luminal mammary cancer stem cells model tumor heterogeneity
Metastatic Triple-Negative Breast Cancer
Prognostic value of proliferation assay in the luminal, HER2-positive, and triple-negative biologic classes of breast cancer
Desmoglein 2 and desmocollin 2 depletions promote malignancy through distinct mechanisms in triple-negative and luminal breast cancer
Triple-negative vimentin-positive heterogeneous feline mammary carcinomas as a potential comparative model for breast cancer
A novel approach to triple-negative breast cancer molecular classification reveals a luminal immune-positive subgroup with good prognoses
BRCAness digitalMLPA profiling predicts benefit of intensified platinum-based chemotherapy in triple-negative and luminal-type breast cancer
Characterizing triple-negative breast cancer tumors
Triple-Negative Breast Cancer: Multimodality Appearance
Mammary adipocytes protect triple-negative breast cancer cells from ferroptosis
Mouse mammary stem cells express prognostic markers for triple-negative breast cancer
Luminal androgen receptor subtype and tumor-infiltrating lymphocytes groups based on triple-negative breast cancer molecular subclassification
Multipotent luminal mammary cancer stem cells model tumor heterogeneity
Metastatic Triple-Negative Breast Cancer
Prognostic value of proliferation assay in the luminal, HER2-positive, and triple-negative biologic classes of breast cancer
Desmoglein 2 and desmocollin 2 depletions promote malignancy through distinct mechanisms in triple-negative and luminal breast cancer
Triple-negative vimentin-positive heterogeneous feline mammary carcinomas as a potential comparative model for breast cancer
A novel approach to triple-negative breast cancer molecular classification reveals a luminal immune-positive subgroup with good prognoses
BRCAness digitalMLPA profiling predicts benefit of intensified platinum-based chemotherapy in triple-negative and luminal-type breast cancer
Characterizing triple-negative breast cancer tumors